Full Year 2024 Synthomer PLC Earnings Call Transcript
Key Points
- Synthomer PLC (SYHMY) reported a robust growth in revenue, EBITDA, EBIT, and improved underlying EPS, all in line with expectations.
- The company achieved a significant 8.4% increase in volumes across all three divisions, despite slow end market demand.
- Synthomer PLC (SYHMY) successfully refinanced its bond in 2024, extending its next major debt maturity to 2027, providing a stable financial platform.
- The company is making strategic progress towards higher margin, more resilient, specialist solutions, with a focus on innovation and sustainability.
- Synthomer PLC (SYHMY) has reduced its manufacturing footprint from 43 sites to 31, allowing for more focused capital allocation and cost reduction.
- Net debt increased at the year-end due to non-recurring outflows such as the EU fine and deferred pension payments.
- The company is facing ongoing challenges in the Construction and Energy Solutions markets, impacting EBITDA margins.
- Higher operating costs due to wage inflation and increased bonus accruals affected all divisions.
- The Health and Protection division's NBR volumes, although improved, are still below pre-pandemic levels, with margins remaining low.
- The company is cautious about market recovery, particularly in the US, and is not relying on significant market improvements in its 2025 plans.
Good morning, and welcome to our 2024 full year results presentation. I'm glad to see you here at the Royal Society of Chemistry in London, with many others joining online. As usual, I'm here with Lily Liu, our CFO, and Faisal Tabbah, Head of Investor Relations. And we look forward to answering your questions at the end.
Starting with our performance, against the backdrop of a period of suppressed demand in the chemical sector that lasts now since three years, we have delivered full year results with robust growth in revenue; EBITDA, EBIT, and improved underlying EPS all in line with expectations. Overall, volumes increased by significant 8.4%, despite generally slow end market demand. All three divisions showed growing volumes. We gained market share, particularly in AS division, and we are pleased to report today an increase in our revenue of 5%.
Our EBITDA increased by 9%, around GBP10 million, mostly reflecting our self-help, reliability, and cost actions, as well as our strategic reorientation with margins
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
